Diabetes & Metabolism Journal

Original Articles

Metabolic Risk/Epidemiology
Effect of Sarcopenia and Body Shape on Cardiovascular Disease According to Obesity Phenotypes: Hyun-Woong Cho, Wankyo Chung, Shinje Moon, Ohk-Hyun Ryu, Min Kyung Kim, Jun Goo Kang; Diabetes Metab J. 2021;45(2):209-218. Published online July 10, 2020; DOI: https://doi.org/10.4093/dmj.2019.0223

8,340 View
212 Download
21 Web of Science
20 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background

This study aimed to assess the effects of sarcopenia and A Body Shape Index (ABSI) on cardiovascular disease (CVD) risk according to obesity phenotypes.

Methods

We used data from the National Health and Nutrition Examination Survey 1999 to 2012. A total of 25,270 adults were included and classified into the following groups: metabolically healthy normal weight (MHNW), metabolically healthy overweight/obese (MHO), metabolically unhealthy normal weight (MUNW), and metabolically unhealthy overweight/obese (MUO). Sarcopenia was defined as the appendicular skeletal mass index <7 kg/m² in men and <5.5kg/m² in women. A multivariate logistic regression analysis was performed to evaluate the odds ratio (OR) of sarcopenia and ABSI for CVD events according to the obesity phenotype.

Results

The MHNW participants with sarcopenia had higher risk for CVD than those without sarcopenia (OR, 2.69; 95% confidence interval [CI], 1.56 to 4.64). In the analysis with MHNW participants without sarcopenia as a reference, the participants with sarcopenia showed a higher OR for CVD than those without sarcopenia in both MHO (OR in participants without sarcopenia, 3.31; 95% CI, 1.94 to 5.64) (OR in participants with sarcopenia, 8.59; 95% CI, 2.63 to 28.04) and MUO participants (OR in participants without sarcopenia, 5.11; 95% CI, 3.21 to 8.15) (OR in participants with sarcopenia, 8.12; 95% CI, 4.04 to 16.32). Participants within the second and third tertiles of ABSI had higher ORs for CVDs than the counterpart of obesity phenotypes within the first tertile.

Conclusion

These results suggest that clinical approaches that consider muscle and body shape are required.

Citations

Citations to this article as recorded by

Association of low muscle mass and obesity with increased all‐cause and cardiovascular disease mortality in US adults
Donghyun Kim, Junghoon Lee, Raekil Park, Chang‐Myung Oh, Shinje Moon
Journal of Cachexia, Sarcopenia and Muscle.2024; 15(1): 240. CrossRef
Metabolic-associated fatty liver disease and sarcopenia: A double whammy
Aditya Viswanath, Sherouk Fouda, Cornelius James Fernandez, Joseph M Pappachan
World Journal of Hepatology.2024; 16(2): 152. CrossRef
Association of Myosteatosis with Nonalcoholic Fatty Liver Disease, Severity, and Liver Fibrosis Using Visual Muscular Quality Map in Computed Tomography
Hwi Seung Kim, Jiwoo Lee, Eun Hee Kim, Min Jung Lee, In Young Bae, Woo Je Lee, Joong-Yeol Park, Hong-Kyu Kim, Chang Hee Jung
Diabetes & Metabolism Journal.2023; 47(1): 104. CrossRef
Additive impact of diabetes and sarcopenia on all-cause and cardiovascular mortality: A longitudinal nationwide population-based study
Eyun Song, Soon Young Hwang, Min Jeong Park, Ahreum Jang, Kyeong Jin Kim, Ji Hee Yu, Nam Hoon Kim, Hye Jin Yoo, Ji A. Seo, Sin Gon Kim, Nan Hee Kim, Sei Hyun Baik, Kyung Mook Choi
Metabolism.2023; 148: 155678. CrossRef
Association between a body shape index and abdominal aortic calcification in general population: A cross-sectional study
Wei Li, Zhenwei Wang, Min Li, Jing Xie, Jing Gong, Naifeng Liu
Frontiers in Cardiovascular Medicine.2023;[Epub] CrossRef
Metabolic Impact of Frailty Changes Diabetes Trajectory
Alan J. Sinclair, Ahmed H. Abdelhafiz
Metabolites.2023; 13(2): 295. CrossRef
Association between sarcopenic obesity and poor muscle quality based on muscle quality map and abdominal computed tomography
Yun Kyung Cho, Han Na Jung, Eun Hee Kim, Min Jung Lee, Joong‐Yeol Park, Woo Je Lee, Hong‐Kyu Kim, Chang Hee Jung
Obesity.2023; 31(6): 1547. CrossRef
Metabolic Characteristics of Frail Older People with Diabetes Mellitus—A Systematic Search for Phenotypes
Ahmed H. Abdelhafiz, Grace L. Keegan, Alan J. Sinclair
Metabolites.2023; 13(6): 705. CrossRef
Risk of Cardiovascular Diseases Among Different Metabolic Obesity Phenotypes: A Prospective Observational Study
Xiaowei Liu, Chan Yang, Yuanyuan Dang, Zhenqi Chang, Juan Li, Yi Zhao, Yuhong Zhang
Metabolic Syndrome and Related Disorders.2023; 21(6): 306. CrossRef
Effect of Hypoxia Conditioning on Body Composition in Middle-Aged and Older Adults: A Systematic Review and Meta-Analysis
Zhijian He, Lijun Qiang, Yusheng Liu, Wenfeng Gao, Tao Feng, Yang Li, Bing Yan, Olivier Girard
Sports Medicine - Open.2023;[Epub] CrossRef
Association Between a Body Shape Index and Subclinical Carotid Atherosclerosis in Population Free of Cardiovascular and Cerebrovascular Diseases
Xiaotian Ma, Lihong Chen, Wenchao Hu, Lanjie He
Journal of Atherosclerosis and Thrombosis.2022; 29(8): 1140. CrossRef
Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease
Vittoria Zambon Azevedo, Cristina Alina Silaghi, Thomas Maurel, Horatiu Silaghi, Vlad Ratziu, Raluca Pais
Frontiers in Nutrition.2022;[Epub] CrossRef
Identification of sarcopenic obesity in adults undergoing orthopaedic surgery: Relationship between “a body shape index” (ABSI) and fat-free mass. A cross -sectional study
Ana Tomažič, Boštjan Žvanut, Lilijana Vouk Grbac, Mihaela Jurdana, Fatih Özden
PLOS ONE.2022; 17(6): e0269956. CrossRef
Associations of Dynapenic Obesity and Sarcopenic Obesity with the Risk of Complications in COVID-19
Laura Pérez-Campos Mayoral, Carlos Alberto Matias-Cervantes, Eduardo Pérez-Campos, Carlos Romero Díaz, Luis Ángel Laguna Barrios, María del Socorro Pina Canseco, Margarito Martínez Cruz, Eduardo Pérez-Campos Mayoral, Carlos Josué Solórzano Mata, Francisco
International Journal of Molecular Sciences.2022; 23(15): 8277. CrossRef
Sex Differences in Adiposity and Cardiovascular Diseases
Haoyun Li, Daniels Konja, Luyao Wang, Yu Wang
International Journal of Molecular Sciences.2022; 23(16): 9338. CrossRef
The Applicability of the ESPEN and EASO-Defined Diagnostic Criteria for Sarcopenic Obesity in Japanese Patients after Stroke: Prevalence and Association with Outcomes
Yoshihiro Yoshimura, Hidetaka Wakabayashi, Fumihiko Nagano, Ayaka Matsumoto, Sayuri Shimazu, Ai Shiraishi, Yoshifumi Kido, Takahiro Bise
Nutrients.2022; 14(19): 4205. CrossRef
The value of combining the simple anthropometric obesity parameters, Body Mass Index (BMI) and a Body Shape Index (ABSI), to assess the risk of non-alcoholic fatty liver disease
Maobin Kuang, Guotai Sheng, Chong Hu, Song Lu, Nan Peng, Yang Zou
Lipids in Health and Disease.2022;[Epub] CrossRef
Sarcopenia and cardiovascular disease in patients with and without kidney disease: what do we know?
Ozkan Gungor, Mustafa Sevinc, Sena Ulu, Ismail Kocyigit
International Urology and Nephrology.2022; 55(5): 1161. CrossRef
Skeletal Muscle Should Not Be Overlooked
Ji A Seo
Diabetes & Metabolism Journal.2021; 45(2): 173. CrossRef
The Role of Sarcopenic Obesity in Cancer and Cardiovascular Disease: A Synthesis of the Evidence on Pathophysiological Aspects and Clinical Implications
Erika Aparecida Silveira, Rômulo Roosevelt da Silva Filho, Maria Claudia Bernardes Spexoto, Fahimeh Haghighatdoost, Nizal Sarrafzadegan, Cesar de Oliveira
International Journal of Molecular Sciences.2021; 22(9): 4339. CrossRef

Obesity and Metabolic Syndrome
The Association between Z-Score of Log-Transformed A Body Shape Index and Cardiovascular Disease in Korea: Wankyo Chung, Jung Hwan Park, Hye Soo Chung, Jae Myung Yu, Shinje Moon, Dong Sun Kim; Diabetes Metab J. 2019;43(5):675-682. Published online April 26, 2019; DOI: https://doi.org/10.4093/dmj.2018.0169

7,764 View
59 Download
3 Web of Science
3 Crossref

Abstract PDF Supplementary Material PubReader

Background

In order to overcome the limitations of body mass index (BMI) and waist circumference (WC), the z-score of the log-transformed A Body Shape Index (LBSIZ) has recently been introduced. In this study, we analyzed the relationship between the LBSIZ and cardiovascular disease (CVD) in a Korean representative sample.

Methods

Data were collected from the Korea National Health and Nutrition Examination VI to V. The association between CVD and obesity indices was analyzed using a receiver operating characteristic curve. The cut-off value for the LBSIZ was estimated using the Youden index, and the odds ratio (OR) for CVD was determined via multivariate logistic regression analysis. ORs according to the LBSIZ value were analyzed using restricted cubic spline regression plots.

Results

A total of 31,227 Korean healthy adults were analyzed. Area under the curve (AUC) of LBSIZ against CVD was 0.686 (95% confidence interval [CI], 0.671 to 0.702), which was significantly higher than the AUC of BMI (0.583; 95% CI, 0.567 to 0.599) or WC (0.646; 95% CI, 0.631 to 0.661) (P<0.001). Similar results were observed for stroke and coronary artery diseases. The cut-off value for the LBSIZ was 0.35 (sensitivity, 64.5%; specificity, 64%; OR, 1.29, 95% CI, 1.12 to 1.49). Under restricted cubic spline regression, LBSIZ demonstrated that OR started to increase past the median value.

Conclusion

The findings of this study suggest that the LBSIZ might be more strongly associated with CVD risks compared to BMI or WC. These outcomes would be helpful for CVD risk assessment in clinical settings, especially the cut-off value of the LBSIZ suggested in this study.

Citations

Citations to this article as recorded by

Body Shape Index and Cardiovascular Risk in Individuals With Obesity
Nazlı Hacıağaoğlu, Can Öner, Hüseyin Çetin, Engin Ersin Şimşek
Cureus.2022;[Epub] CrossRef
Association between body shape index and risk of mortality in the United States
Heysoo Lee, Hye Soo Chung, Yoon Jung Kim, Min Kyu Choi, Yong Kyun Roh, Wankyo Chung, Jae Myung Yu, Chang-Myung Oh, Shinje Moon
Scientific Reports.2022;[Epub] CrossRef
Utility of the Z-score of log-transformed A Body Shape Index (LBSIZ) in the assessment for sarcopenic obesity and cardiovascular disease risk in the United States
Wankyo Chung, Jung Hwan Park, Hye Soo Chung, Jae Myung Yu, Dong Sun Kim, Shinje Moon
Scientific Reports.2019;[Epub] CrossRef

Clinical Diabetes & Therapeutics
Association between Serum Selenium Level and the Presence of Diabetes Mellitus: A Meta-Analysis of Observational Studies: Juno Kim, Hye Soo Chung, Min-Kyu Choi, Yong Kyun Roh, Hyung Joon Yoo, Jung Hwan Park, Dong Sun Kim, Jae Myung Yu, Shinje Moon; Diabetes Metab J. 2019;43(4):447-460. Published online January 2, 2019; DOI: https://doi.org/10.4093/dmj.2018.0123

6,316 View
99 Download
35 Web of Science
35 Crossref

Abstract PDF Supplementary Material PubReader

Background

Epidemiological studies have suggested an association between selenium (Se) and diabetes mellitus (DM). However, different studies have reported conflicting results. Therefore, we performed a comprehensive meta-analysis to clarify the impact of Se on DM.

Methods

We searched the PubMed database for studies on the association between Se and DM from inception to June 2018.

Results

Twenty articles evaluating 47,930 participants were included in the analysis. The meta-analysis found that high levels of Se were significantly associated with the presence of DM (pooled odds ratios [ORs], 1.88; 95% confidence interval [CI], 1.44 to 2.45). However, significant heterogeneity was found (I²=82%). Subgroup analyses were performed based on the Se measurement methods used in each study. A significant association was found between high Se levels and the presence of DM in the studies that used blood (OR, 2.17; 95% CI, 1.60 to 2.93; I²=77%), diet (OR, 1.61; 95% CI, 1.10 to 2.36; I²=0%), and urine (OR, 1.49; 95% CI, 1.02 to 2.17; I²=0%) as samples to estimate Se levels, but not in studies on nails (OR, 1.24; 95% CI, 0.52 to 2.98; I²=91%). Because of significant heterogeneity in the studies with blood, we conducted a sensitivity analysis and tested the publication bias. The results were consistent after adjustment based on the sensitivity analysis as well as the trim and fill analysis for publication bias.

Conclusion

This meta-analysis demonstrates that high levels of Se are associated with the presence of DM. Further prospective and randomized controlled trials are warranted to elucidate the link better.

Citations

Citations to this article as recorded by

Increased Expression of PHGDH Under High-Selenium Stress In Vivo
Qin Wang, Jianrong Wang, Xue Zhang, Yiqun Liu, Feng Han, Xuesong Xiang, Yanbin Guo, Zhen-wu Huang
Biological Trace Element Research.2024;[Epub] CrossRef
Dosage-effect of selenium supplementation on blood glucose and oxidative stress in type 2 diabetes mellitus and normal mice
Xiaxia Cai, Zhuo Hu, Mingyuan Zhang, Qinyu Dang, Qian Yang, Xiaoyan Zhao, Yandi Zhu, Yadi Zhang, Yuchen Wei, Haiqin Fang, Huanling Yu
Journal of Trace Elements in Medicine and Biology.2024; 83: 127410. CrossRef
Immunomodulation through Nutrition Should Be a Key Trend in Type 2 Diabetes Treatment
Katarzyna Napiórkowska-Baran, Paweł Treichel, Marta Czarnowska, Magdalena Drozd, Kinga Koperska, Agata Węglarz, Oskar Schmidt, Samira Darwish, Bartłomiej Szymczak, Zbigniew Bartuzi
International Journal of Molecular Sciences.2024; 25(7): 3769. CrossRef
Biological Activity of Selenium and Its Impact on Human Health
Giuseppe Genchi, Graziantonio Lauria, Alessia Catalano, Maria Stefania Sinicropi, Alessia Carocci
International Journal of Molecular Sciences.2023; 24(3): 2633. CrossRef
The Role of Selenium and Manganese in the Formation, Diagnosis and Treatment of Cervical, Endometrial and Ovarian Cancer
Anna Golara, Mateusz Kozłowski, Paweł Guzik, Sebastian Kwiatkowski, Aneta Cymbaluk-Płoska
International Journal of Molecular Sciences.2023; 24(13): 10887. CrossRef
Association of Selenium Intake and Selenium Concentrations with Risk of Type 2 Diabetes in Adults: A Narrative Review
Maha Alharithy, Nora Alafif
Metabolites.2023; 13(6): 767. CrossRef
Selenium-Containing Organic Fertilizer Application Affects Yield, Quality, and Distribution of Selenium in Wheat
Peng Chen, Hiba Shaghaleh, Yousef Alhaj Hamoud, Jing Wang, Wenxia Pei, Xianfu Yuan, Jianjian Liu, Cece Qiao, Wenhui Xia, Jianfei Wang
Life.2023; 13(9): 1849. CrossRef
Selenium Species in Diabetes Mellitus Type 2
Krystyna Pyrzynska, Aleksandra Sentkowska
Biological Trace Element Research.2023;[Epub] CrossRef
A Comprehensive Review on Selenium and Its Effects on Human Health and Distribution in Middle Eastern Countries
Marek Kieliszek, Iqra Bano, Hamed Zare
Biological Trace Element Research.2022; 200(3): 971. CrossRef
Selenium and clarithromycin loaded PLA-GO composite wound dressings by electrospinning method
Fatih Ciftci, Sumeyra Ayan, Nilüfer Duygulu, Yasemin Yilmazer, Zeynep Karavelioglu, Meyrem Vehapi, Rabia Cakır Koc, Mustafa Sengor, Hakan Yılmazer, Didem Ozcimen, Oguzhan Gunduz, Cem Bulent Ustundag
International Journal of Polymeric Materials and Polymeric Biomaterials.2022; 71(12): 898. CrossRef
The role of selenium in type-2 diabetes mellitus and its metabolic comorbidities
Holger Steinbrenner, Leonidas H. Duntas, Margaret P. Rayman
Redox Biology.2022; 50: 102236. CrossRef
The Role of Selenium in Pathologies: An Updated Review
Giulia Barchielli, Antonella Capperucci, Damiano Tanini
Antioxidants.2022; 11(2): 251. CrossRef
Selenium and Selenoproteins at the Intersection of Type 2 Diabetes and Thyroid Pathophysiology
Francesca Gorini, Cristina Vassalle
Antioxidants.2022; 11(6): 1188. CrossRef
Higher selenium was associated with higher risk of diabetes: Consistent evidence from longitudinal and cross-sectional studies based on nail and serum selenium measures
Ranqi Shao, Liqin Su, Li Li, Jinghuan Wu, Xiaohong He, Deqian Mao, Yibin Cheng, Jingyi Liu, Chen Chen, Yinlong Jin, Sujuan Gao
Science of The Total Environment.2022; 840: 156618. CrossRef
The Roles and Pathogenesis Mechanisms of a Number of Micronutrients in the Prevention and/or Treatment of Chronic Hepatitis, COVID-19 and Type-2 Diabetes Mellitus
Khalid M. Sumaily
Nutrients.2022; 14(13): 2632. CrossRef
Associations between Circulating SELENOP Level and Disorders of Glucose and Lipid Metabolism: A Meta-Analysis
Ruirui Yu, Zhoutian Wang, Miaomiao Ma, Ping Xu, Longjian Liu, Alexey A. Tinkov, Xin Gen Lei, Ji-Chang Zhou
Antioxidants.2022; 11(7): 1263. CrossRef
Cross-Sectional Association of Blood Selenium with Glycemic Biomarkers among U.S. Adults with Normoglycemia in the National Health and Nutrition Examination Survey 2013–2016
Jingli Yang, En Chen, Cheukling Choi, Kayue Chan, Qinghua Yang, Juwel Rana, Bo Yang, Chuiguo Huang, Aimin Yang, Kenneth Lo
Nutrients.2022; 14(19): 3972. CrossRef
Plasma and vitreous selenium concentrations in patients with type 2 diabetes and diabetic retinopathy
Chunmiao Wang, Ruijin Ran, Xin Jin, Xiaohong Zhu
Medicine.2022; 101(39): e30877. CrossRef
Emerging roles of selenium on metabolism and type 2 diabetes
Jiuxiang Zhao, Hong Zou, Yanling Huo, Xiaoyi Wei, Yu Li
Frontiers in Nutrition.2022;[Epub] CrossRef
Selenium: Role in preserving and improving health and preventing disease
Goran Belojević
Galenika Medical Journal.2022; 1(4): 90. CrossRef
A comprehensive review on the neuropathophysiology of selenium
Mohammad Naderi, Pankaj Puar, Mahtab Zonouzi-Marand, Douglas P. Chivers, Som Niyogi, Raymond W.M. Kwong
Science of The Total Environment.2021; 767: 144329. CrossRef
Dietary selenium intake and risk of hospitalization for type 2 diabetes in the Moli-sani study cohort
Marco Vinceti, Marialaura Bonaccio, Tommaso Filippini, Simona Costanzo, Lauren A. Wise, Augusto Di Castelnuovo, Emilia Ruggiero, Mariarosaria Persichillo, Chiara Cerletti, Maria Benedetta Donati, Giovanni de Gaetano, Licia Iacoviello
Nutrition, Metabolism and Cardiovascular Diseases.2021; 31(6): 1738. CrossRef
A systematic review and dose-response meta-analysis of exposure to environmental selenium and the risk of type 2 diabetes in nonexperimental studies
Marco Vinceti, Tommaso Filippini, Lauren A. Wise, Kenneth J. Rothman
Environmental Research.2021; 197: 111210. CrossRef
Selenium as a Bioactive Micronutrient in the Human Diet and Its Cancer Chemopreventive Activity
Dominika Radomska, Robert Czarnomysy, Dominik Radomski, Anna Bielawska, Krzysztof Bielawski
Nutrients.2021; 13(5): 1649. CrossRef
Selenium in Human Health and Gut Microflora: Bioavailability of Selenocompounds and Relationship With Diseases
Rannapaula Lawrynhuk Urbano Ferreira, Karine Cavalcanti Maurício Sena-Evangelista, Eduardo Pereira de Azevedo, Francisco Irochima Pinheiro, Ricardo Ney Cobucci, Lucia Fatima Campos Pedrosa
Frontiers in Nutrition.2021;[Epub] CrossRef
Ferroptosis and Its Potential Role in Metabolic Diseases: A Curse or Revitalization?
Jia-Yue Duan, Xiao Lin, Feng Xu, Su-Kang Shan, Bei Guo, Fu-Xing-Zi Li, Yi Wang, Ming-Hui Zheng, Qiu-Shuang Xu, Li-Min Lei, Wen-Lu Ou-Yang, Yun-Yun Wu, Ke-Xin Tang, Ling-Qing Yuan
Frontiers in Cell and Developmental Biology.2021;[Epub] CrossRef
Selenium Intake and Glycemic Control in Young Adults With Normal-Weight Obesity Syndrome
Acsa de Castro Santos, Anna Flavia Ferreira Passos, Luciana Carla Holzbach, Cristiane Cominetti
Frontiers in Nutrition.2021;[Epub] CrossRef
Development and Therapeutic Potential of Selenazo Compounds
Ana Carolina Ruberte, Carmen Sanmartin, Carlos Aydillo, Arun K. Sharma, Daniel Plano
Journal of Medicinal Chemistry.2020; 63(4): 1473. CrossRef
Selenium in thyroid disorders — essential knowledge for clinicians
Kristian Hillert Winther, Margaret Philomena Rayman, Steen Joop Bonnema, Laszlo Hegedüs
Nature Reviews Endocrinology.2020; 16(3): 165. CrossRef
Safety of selenium‐enriched biomass of Yarrowia lipolytica as a novel food pursuant to Regulation (EU) 2015/2283
Dominique Turck, Jacqueline Castenmiller, Stefaan De Henauw, Karen Ildico Hirsch‐Ernst, John Kearney, Alexandre Maciuk, Inge Mangelsdorf, Harry J McArdle, Androniki Naska, Carmen Pelaez, Kristina Pentieva, Alfonso Siani, Frank Thies, Sophia Tsabouri, Marc
EFSA Journal.2020;[Epub] CrossRef
The Association of Circulating Selenium Concentrations with Diabetes Mellitus

Xiao-Long Liao, Zhong-Hua Wang, Xiu-Na Liang, Jun Liang, Xue-Biao Wei, Shou-Hong Wang, Wei-Xin Guo
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2020; Volume 13: 4755. CrossRef
A 2018 European Thyroid Association Survey on the Use of Selenium Supplementation in Hashimoto’s Thyroiditis
Kristian Hillert Winther, Enrico Papini, Roberto Attanasio, Roberto Negro, Laszlo Hegedüs
European Thyroid Journal.2020; 9(2): 99. CrossRef
Systems Biology of Selenium and Complex Disease
Huimin Ying, Yan Zhang
Biological Trace Element Research.2019; 192(1): 38. CrossRef
Effectiveness and safety of selenium supplementation for type 2 diabetes mellitus in adults: a systematic review of randomised controlled trials
A. Stróżyk, Z. Osica, J. D. Przybylak, M. Kołodziej, B. M. Zalewski, B. Mrozikiewicz‐Rakowska, H. Szajewska
Journal of Human Nutrition and Dietetics.2019; 32(5): 635. CrossRef
Selenium and Health: An Update on the Situation in the Middle East and North Africa
Sohayla A. Z. Ibrahim, Abdelhamid Kerkadi, Abdelali Agouni
Nutrients.2019; 11(7): 1457. CrossRef

First
Prev
Page of 1
Next
Last

Search